Research Article
KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico
Table 2
KIR and HLA gene frequencies in SSc patients and CS.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CF: Carrier Frequencies; GF: Gene Frequencies; KIR: Killer-cell Immunoglobulin-like Receptors; HLA: Human Leukocyte Antigen; SSc: Systemic Sclerosis; CS: Control Subjects; CI: Confidence Interval. KIR2DS4full/del includes individuals with a copy of the full gene and del variant; 2DS4full includes individuals with one or two copies of the full gene; 2DS4del includes individuals with one or two copies of the del variant; and 2DS4neg includes individuals without KIR2DS4. based on Fisher’s exact test and adjusted based on Holm-Bonferroni correction for multiple comparisons. |